KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Change in Account Payables (2016 - 2025)

Charles River Laboratories International has reported Change in Account Payables over the past 17 years, most recently at -$37.9 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 427.84% year-over-year to -$37.9 million; the TTM value through Dec 2025 reached $2.9 million, up 120.1%, while the annual FY2025 figure was $2.9 million, 120.1% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$37.9 million at Charles River Laboratories International, down from $24.5 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $40.9 million in Q1 2022 and troughed at -$41.3 million in Q2 2023.
  • A 5-year average of $521000.0 and a median of -$1.1 million in 2023 define the central range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 3818.66% in 2025 and fell as far as 528.03% in 2025.
  • Year by year, Change in Account Payables stood at $33.5 million in 2021, then plummeted by 125.79% to -$8.6 million in 2022, then skyrocketed by 170.72% to $6.1 million in 2023, then tumbled by 217.56% to -$7.2 million in 2024, then tumbled by 427.84% to -$37.9 million in 2025.
  • Business Quant data shows Change in Account Payables for CRL at -$37.9 million in Q4 2025, $24.5 million in Q3 2025, and -$9.0 million in Q2 2025.